EUVIMEDEUVIMED entdecken
Crossref

Up-regulation of SET nuclear proto-oncogene is associated with early recurrence and poorer prognosis of hepatocellular carcinoma

Gio Van Nguyen, Manh Cong Tran, Lam Van Nguyen, Hoa Quynh Tran, Minh Nam Nguyen

Science & Technology Development Journal - Health Sciences · 2021

DOI: 10.32508/stdjhs.v2i1.451 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science & Technology Development Journal - Health Sciences, 2021. Verfasst von Gio Van Nguyen und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Overview: Hepatocellular carcinoma is a complex disease and has a high mortality rate. Identifying biomarkers that can use to diagnose early and prognosis of HCC is essential to reduce the burden of HCC on patients, families, and society.

Methods

The bioinformatics methods were used to study the expression of the SET nuclear proto-oncogene gene in cells, tissues, and the correlation of SET with hepatocellular carcinoma. The data from the open databases were used in this study include COMPARTMENTS, Kaplan-Meier Plotter, STRING, TIMER, UALCAN, The Cancer Genome Atlas database, and Gene Expression Omnibus.

Results

At the cellular level, the expression level of the SET gene was highest in the nucleus, endoplasmic reticulum, cytosol. The SET gene's mRNA expression appeared in all body tissues. The TPM median of the SET gene in liver tissue was 33.42. The expression level of SET in hepatocellular carcinoma tissue was higher than that in non-cancer tissue for both males and females. The SET gene is an independent factor for the diagnosis and prognosis of HCC. Patients with high SET expression have a short survival time and a higher rate of recurrence than patients with low SET expression. The SET expression has a significant correlation with B cells, CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and especially dendritic cells in hepatocellular carcinoma.

Conclusion

High expression level of SET related to a poor prognosis in patients with hepatocellular carcinoma. This study demonstrates that the SET is a potential biomarker for early diagnosis and prognosis of hepatocellular carcinoma.

Zitieren

APA

Nguyen, G. V., Tran, M. C., Nguyen, L. V., Tran, H. Q., & Nguyen, M. N. (2021). Up-regulation of SET nuclear proto-oncogene is associated with early recurrence and poorer prognosis of hepatocellular carcinoma. Science & Technology Development Journal - Health Sciences. https://doi.org/10.32508/stdjhs.v2i1.451

Vancouver

Nguyen GV, Tran MC, Nguyen LV, Tran HQ, Nguyen MN. Up-regulation of SET nuclear proto-oncogene is associated with early recurrence and poorer prognosis of hepatocellular carcinoma. Science & Technology Development Journal - Health Sciences. 2021. doi:10.32508/stdjhs.v2i1.451

BibTeX
@article{Nguyen2021,
  author = {Nguyen, Gio Van and Tran, Manh Cong and Nguyen, Lam Van and Tran, Hoa Quynh and Nguyen, Minh Nam},
  title = {Up-regulation of SET nuclear proto-oncogene is associated with early recurrence and poorer prognosis of hepatocellular carcinoma},
  journal = {Science & Technology Development Journal - Health Sciences},
  year = {2021},
  doi = {10.32508/stdjhs.v2i1.451}
}
Kostenlos starten →